Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five
Read more
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five
Read moreThe treatment of relapsed or refractory follicular lymphoma (RRFL) is distinct from patients who are receiving treatment for the first
Read more